Need Legal Help?
Start Here for a Free Case Review!
Trasylol Aprotinin Injection
Find a Lawyer in Your State
Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall aprotinin-trasylolTrasylol Kidney Failure
The heart surgery drug Trasylol (aprontinin) has been correlated with a heightened risk of kidney failure. Trasylol is commonly prescribed to patients undergoing heart surgery for blocked coronary arteries and other more complicated cardiovascular complications to control bleeding and induce clotting. An independent study released in January of 2006 suggests that the severity of Trasylol kidney failure risk may be as high as twice the risk of alternative medications, in addition to posing other serious side effects such as heart attack, stroke, and heart failure.
The Study
Pharmaceutical company, Bayer AG released Trasylol in 1993 following approval from the Food and Drug Administration. Reports of consistent adverse side effects have led researchers to believe that pretrial testing for the drug was insufficient. Dr. Dennis T. Mangano, who facilitated the research on Trasylol kidney failure, studied a sampling of heart surgery patients that was comprised of people taking Trasylol, people taking alternative medications, and those taking no medication at all for controlling blood loss.
Trasylol Side Effects
In addition to exhibiting double the risk for Trasylol kidney failure, patients taking the medication showed a 50 percent increased risk of heart attack, a 109 percent increase in risk of heart failure, and an alarming 181 percent increased risk of experiencing a stroke . Patients taking alternative medications comparatively experienced no signs of increased risk for kidney failure or any of the other adverse side effects.
Many doctors and surgeons involved with cardiovascular healthcare have expressed concern regarding Trasylol kidney failure since the initial release of the drug. However, results of the independent study are only now expected to impact sales and availability of Trasylol. Bayer has responded to the newly reported findings with skepticism, alleging that substantial testing was conducted prior to and during the drugs availability and produced results inconsistent with Dr. Mangano''s findings.
Alternative Medications
Alternative medications for controlling bleeding during heart surgery such as aminocaproic acid and tranexamic acid have proven to be safe and effective substitutes for Trasylol that do not present the same serious side effects. Patients involved in Dr. Mangano''s research who were taking Trasylol alternatives, showed no signs of increased risk for Trasylol kidney failure, heart attack, or stroke. Aminocaproic acid and tranexamic acid are also significantly less costly options in comparison with Trasylol.
Researchers have estimated had alternative medications been used as opposed to Trasylol, $1 billion in healthcare costs could have been saved.
Dr. Mangano has commented that he could not in good conscious give Trasylol to any patient knowing that there are safe and effective alternative medications. “The least that should be done is to inform the patient that the risk of going on dialysis is increased 2 to 3 fold and there are alternatives,” the doctor added.
Have you experienced kidney failure due to Trasylol?
If you or a loved one has experienced Trasylol kidney failure, due to taking the medication, you may be entitled to compensation for your losses and suffering. Contact us to speak to a qualified Trasylol attorney who can help you understand your legal rights and maximize your claims. We will evaluate your case, free of charge , and provide you with the knowledge necessary to protect your best interest.
Defective Drugs Breaking News
"Trasylol Linked to Risk of Death"
A rigorous study involving the heart surgery drug Trasylol is likely to seal the drug’s fate, as researchers are left with little doubt of the greater ...
"Heart Surgery Drug Risks Confirmed"
The heart surgery drug, Trasylol, increases the risk of death and kidney damage in patients, two new studies have confirmed.
Trasylol (aprotinin) is given to patien...
"FDA Suspends Sale of Trasylol Because of Death Risk"
Sales of the heart surgery drug Trasylol are being suspended as concerns continue to mount over the increased risk of death, the Food and Drug Administration announced Monday...
Other Areas of Drug Recall
- |
- Accutane |
- Acetaminophen |
- Adderall |
- Amiodarone |
- Androstenedione |
- Trasylol - Aprotinin Injection |
- Arava |
- Avandia |
- Baycol |
- Baytril |
- Bextra |
- Celebrex |
- Cellcept |
- Chantix |
- Cipro Side Effects |
- Cold-Eeze |
- Crestor |
- Defective Drug FAQ |
- Common Defective Drugs |
- Depakote |
- Digitek |
- Drug Company Information |
- Defective Drug Side Effects |
- Ephedrine and Metabolife |
- Erythromycin |
- Exjade |
- Fentanyl Patch |
- Fen Phen |
- Floxin and Noroxin |
- Fluoroquinolone Antibiotics |
- Fosamax |
- Gadolinium |
- Gatifloxacin |
- Geodon |
- Gleevec |
- Heparin |
- Humira and Remicade |
- Kava Kava |
- Ketek |
- Lariam |
- Levaquin Lawsuit |
- Meridia |
- Naproxen (Aleve) |
- Natrecor |
- Neurontin |
- Nuvaring |
- Oxycontin |
- Palladone |
- Paxil |
- Permax |
- Plavix |
- PPA |
- Procrit |
- Protopic |
- Prozac |
- What is Quinine? |
- Remicade Lawsuit |
- Rezulin |
- Risperdal |
- Ritalin |
- Serevent |
- Seroquel |
- Serzone |
- Tequin |
- Thimerosal |
- Viagra |
- Viga |
- Vioxx |
- Zelnorm |
- Zicam |
- Zoloft |
- Zyprexa |